A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
Clinical trial NCT01649856 · COMPLETED
Trial details
- NCT number
- NCT01649856
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-24
- Primary completion
- 2014-10-21
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.